446 related articles for article (PubMed ID: 30421798)
1. Inflammation in osteoarthritis: is it time to dampen the alarm(in) in this debilitating disease?
van den Bosch MHJ
Clin Exp Immunol; 2019 Feb; 195(2):153-166. PubMed ID: 30421798
[TBL] [Abstract][Full Text] [Related]
2. S100A8/A9 increases the mobilization of pro-inflammatory Ly6C
Cremers NAJ; van den Bosch MHJ; van Dalen S; Di Ceglie I; Ascone G; van de Loo F; Koenders M; van der Kraan P; Sloetjes A; Vogl T; Roth J; Geven EJW; Blom AB; van Lent PLEM
Arthritis Res Ther; 2017 Sep; 19(1):217. PubMed ID: 28969686
[TBL] [Abstract][Full Text] [Related]
3. The danger from within: alarmins in arthritis.
Nefla M; Holzinger D; Berenbaum F; Jacques C
Nat Rev Rheumatol; 2016 Nov; 12(11):669-683. PubMed ID: 27733758
[TBL] [Abstract][Full Text] [Related]
4. Active involvement of alarmins S100A8 and S100A9 in the regulation of synovial activation and joint destruction during mouse and human osteoarthritis.
van Lent PL; Blom AB; Schelbergen RF; Slöetjes A; Lafeber FP; Lems WF; Cats H; Vogl T; Roth J; van den Berg WB
Arthritis Rheum; 2012 May; 64(5):1466-76. PubMed ID: 22143922
[TBL] [Abstract][Full Text] [Related]
5. Danger signals and inflammaging in osteoarthritis.
Millerand M; Berenbaum F; Jacques C
Clin Exp Rheumatol; 2019; 37 Suppl 120(5):48-56. PubMed ID: 31621566
[TBL] [Abstract][Full Text] [Related]
6. Alarmins S100A8/S100A9 aggravate osteophyte formation in experimental osteoarthritis and predict osteophyte progression in early human symptomatic osteoarthritis.
Schelbergen RF; de Munter W; van den Bosch MH; Lafeber FP; Sloetjes A; Vogl T; Roth J; van den Berg WB; van der Kraan PM; Blom AB; van Lent PL
Ann Rheum Dis; 2016 Jan; 75(1):218-25. PubMed ID: 25180294
[TBL] [Abstract][Full Text] [Related]
7. Treatment efficacy of adipose-derived stem cells in experimental osteoarthritis is driven by high synovial activation and reflected by S100A8/A9 serum levels.
Schelbergen RF; van Dalen S; ter Huurne M; Roth J; Vogl T; Noël D; Jorgensen C; van den Berg WB; van de Loo FA; Blom AB; van Lent PL
Osteoarthritis Cartilage; 2014 Aug; 22(8):1158-66. PubMed ID: 24928317
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic treatment with S100A9 inhibitor paquinimod reduces pathology in experimental collagenase-induced osteoarthritis.
Schelbergen RF; Geven EJ; van den Bosch MH; Eriksson H; Leanderson T; Vogl T; Roth J; van de Loo FA; Koenders MI; van der Kraan PM; van den Berg WB; Blom AB; van Lent PL
Ann Rheum Dis; 2015 Dec; 74(12):2254-8. PubMed ID: 25969431
[TBL] [Abstract][Full Text] [Related]
9. Damage-associated molecular patterns in the pathogenesis of osteoarthritis: potentially novel therapeutic targets.
Rosenberg JH; Rai V; Dilisio MF; Agrawal DK
Mol Cell Biochem; 2017 Oct; 434(1-2):171-179. PubMed ID: 28474284
[TBL] [Abstract][Full Text] [Related]
10. Alarmin S100A9 Induces Proinflammatory and Catabolic Effects Predominantly in the M1 Macrophages of Human Osteoarthritic Synovium.
van den Bosch MH; Blom AB; Schelbergen RF; Koenders MI; van de Loo FA; van den Berg WB; Vogl T; Roth J; van der Kraan PM; van Lent PL
J Rheumatol; 2016 Oct; 43(10):1874-1884. PubMed ID: 27481901
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory mediators in osteoarthritis: A critical review of the state-of-the-art, current prospects, and future challenges.
Rahmati M; Mobasheri A; Mozafari M
Bone; 2016 Apr; 85():81-90. PubMed ID: 26812612
[TBL] [Abstract][Full Text] [Related]
12. Induction of Canonical Wnt Signaling by the Alarmins S100A8/A9 in Murine Knee Joints: Implications for Osteoarthritis.
van den Bosch MH; Blom AB; Schelbergen RF; Vogl T; Roth JP; Slöetjes AW; van den Berg WB; van der Kraan PM; van Lent PL
Arthritis Rheumatol; 2016 Jan; 68(1):152-63. PubMed ID: 26360647
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of TLR4 signalling to dampen joint inflammation in osteoarthritis.
Bartels YL; van Lent PLEM; van der Kraan PM; Blom AB; Bonger KM; van den Bosch MHJ
Rheumatology (Oxford); 2024 Mar; 63(3):608-618. PubMed ID: 37788083
[TBL] [Abstract][Full Text] [Related]
14. The role of innate immunity in osteoarthritis: when our first line of defense goes on the offensive.
Orlowsky EW; Kraus VB
J Rheumatol; 2015 Mar; 42(3):363-71. PubMed ID: 25593231
[TBL] [Abstract][Full Text] [Related]
15. Identifying effector molecules, cells, and cytokines of innate immunity in OA.
van den Bosch MHJ; van Lent PLEM; van der Kraan PM
Osteoarthritis Cartilage; 2020 May; 28(5):532-543. PubMed ID: 32044352
[TBL] [Abstract][Full Text] [Related]
16. [Inflammation and osteoarthritis-related pain].
Nees TA; Rosshirt N; Reiner T; Schiltenwolf M; Moradi B
Schmerz; 2019 Feb; 33(1):4-12. PubMed ID: 30560495
[TBL] [Abstract][Full Text] [Related]
17. Amniotic mesenchymal stem cells mitigate osteoarthritis progression in a synovial macrophage-mediated in vitro explant coculture model.
Topoluk N; Steckbeck K; Siatkowski S; Burnikel B; Tokish J; Mercuri J
J Tissue Eng Regen Med; 2018 Apr; 12(4):1097-1110. PubMed ID: 29131526
[TBL] [Abstract][Full Text] [Related]
18. Immune Contributions to Osteoarthritis.
Lopes EBP; Filiberti A; Husain SA; Humphrey MB
Curr Osteoporos Rep; 2017 Dec; 15(6):593-600. PubMed ID: 29098574
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-1 is not involved in synovial inflammation and cartilage destruction in collagenase-induced osteoarthritis.
van Dalen SC; Blom AB; Slöetjes AW; Helsen MM; Roth J; Vogl T; van de Loo FA; Koenders MI; van der Kraan PM; van den Berg WB; van den Bosch MH; van Lent PL
Osteoarthritis Cartilage; 2017 Mar; 25(3):385-396. PubMed ID: 27654963
[TBL] [Abstract][Full Text] [Related]
20. Adenoviral gene transfer into osteoarthritis synovial cells using the endogenous inhibitor IkappaBalpha reveals that most, but not all, inflammatory and destructive mediators are NFkappaB dependent.
Amos N; Lauder S; Evans A; Feldmann M; Bondeson J
Rheumatology (Oxford); 2006 Oct; 45(10):1201-9. PubMed ID: 16571608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
